Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis

Fig. 6

Comparison of liver and renal injury, arrhythmia and fever between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone through thoracic perfusion for treating MPE. a Comparison of liver and renal injury between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone; b Comparison of arrhythmia between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone; c Comparison of fever between Endostar combined with chemotherapeutic agents versus chemotherapeutic agents alone; OR = odds ratio; MPE, malignant pleural effusions

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us